ORGS Orgenesis
- 0.519
- +0.012+2.33%
Orgenesis News
Express News | Orgenesis Inc Files For Mixed Shelf Of Up To $100M- Sec Filing
Express News | Orgenesis Inc Files for Mixed Shelf of up to $100 Mln- SEC Filing
Express News | Orgenesis Says Major Transformation Underway Commencing With Recent Acquisition; Says Recently Secured $2.3M Investment
Express News | Orgenesis Inc - Looking Forward, Our First Major Step in Transformation Was Recent Transaction to Regain 100% Ownership of Octomera
Express News | Orgenesis-Enteredinto Asset Purchase and Strategic Collaboration Agreement Which to Provide Octomera With Over $8 Mln of Initial Collaboration Payments
Express News | Orgenesis Inc - Major Transformation Underway Commencing Withrecent Acquisitionreassertingfull Ownership and Control Over Octomera
Express News | Orgenesis Provides Year End Business Update
Express News | Orgenesis- Board Determined Co's Financial Statements for Qtrs Ended March 31, 2023, June 30, 2023, Sept 30, 2023, Should No Longer Be Relied Upon
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersAdial Pharmaceuticals (NASDAQ:ADIL) shares rose 61.6% to $1.83 during Wednesday's regular session. The company's market cap stands at $7.4 million. Jaguar Health (NASDAQ:JAGX) shares rose 32.22
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
ORMOND BEACH, Fla. and GERMANTOWN, Md., April 10, 2024 (GLOBE NEWSWIRE) -- Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (NASDAQ:ORGS), a global leader in
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersOrgenesis (NASDAQ:ORGS) shares increased by 8.5% to $0.63 during Thursday's after-market session. The company's market cap stands at $21.4 million. AN2 Therapeutics (NASDAQ:ANTX) shares increas
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersARCA biopharma (NASDAQ:ABIO) stock moved upwards by 124.6% to $3.84 during Wednesday's pre-market session. The market value of their outstanding shares is at $55.6 million. Kintara Therapeutics
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersNexalin Technology (NASDAQ:NXL) stock increased by 47.9% to $2.81 during Tuesday's regular session. The market value of their outstanding shares is at $20.4 million. MSP Recovery (NASDAQ:LIFW)
Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More
Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
GERMANTOWN, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global leader in decentralizing cell and gene therapies (CGTs), today announced that its CEO, Vered
Express News | Orgenesis Consortium Awarded €1.5M Grant From Walloon Government In Belgium For EXOFASTTRACK Project Dedicated to Accelerated Development Of Multiple Therapeutic Exosomes
Orgenesis Consortium Awarded €1.5M EUR Grant From the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
GERMANTOWN, Md., March 13, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global leader in decentralizing cell and gene therapies (CGTs), today announced that the Company has
Express News | Orgenesis Announces $2.3M Private Placement
Express News | Orgenesis Consortium Awarded €2.0M EUR Grant From Walloon Government For MAIDAM AI Project
Press Release: Orgenesis Consortium Awarded EUR2.0M EUR Grant From Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
Orgenesis Consortium Awarded EUR2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing GERMANTOWN, Md., Feb. 29, 2024 (GLOBE NEWSWIRE)
Analysis
Price Target
No Data
